Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | CSF3R |
Variant | S669G |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | CSF3R S669G lies within the cytoplasmic domain of the Csf3r protein (UniProt.org). S669G has not been characterized in the scientific literature and therefore, its effect on Csf3r protein function is unknown (PubMed, Aug 2024). |
Associated Drug Resistance | |
Category Variants Paths |
CSF3R mutant CSF3R S669G |
Transcript | NM_000760.4 |
gDNA | chr1:g.36467265T>C |
cDNA | c.2005A>G |
Protein | p.S669G |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_017000370 | chr1:g.36467265T>C | c.2005A>G | p.S669G | RefSeq | GRCh38/hg38 |
XM_017000370.1 | chr1:g.36467265T>C | c.2005A>G | p.S669G | RefSeq | GRCh38/hg38 |
XM_047446753.1 | chr1:g.36467265T>C | c.2005A>G | p.S669G | RefSeq | GRCh38/hg38 |
XM_011540748 | chr1:g.36467265T>C | c.2005A>G | p.S669G | RefSeq | GRCh38/hg38 |
NM_156039.3 | chr1:g.36467265T>C | c.2005A>G | p.S669G | RefSeq | GRCh38/hg38 |
NM_000760.4 | chr1:g.36467265T>C | c.2005A>G | p.S669G | RefSeq | GRCh38/hg38 |
NM_156039 | chr1:g.36467265T>C | c.2005A>G | p.S669G | RefSeq | GRCh38/hg38 |
NM_156039.3 | chr1:g.36467265T>C | c.2005A>G | p.S669G | RefSeq | GRCh38/hg38 |
NM_000760 | chr1:g.36467265T>C | c.2005A>G | p.S669G | RefSeq | GRCh38/hg38 |
NM_000760.3 | chr1:g.36467265T>C | c.2005A>G | p.S669G | RefSeq | GRCh38/hg38 |
XM_011540748.3 | chr1:g.36467265T>C | c.2005A>G | p.S669G | RefSeq | GRCh38/hg38 |
NM_172313.2 | chr1:g.36467265T>C | c.2005A>G | p.S669G | RefSeq | GRCh38/hg38 |
NM_172313 | chr1:g.36467265T>C | c.2005A>G | p.S669G | RefSeq | GRCh38/hg38 |
NM_172313.3 | chr1:g.36467265T>C | c.2005A>G | p.S669G | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|